Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma

European Journal of Cancer

Volumn 39, Issue 3, 2003, Pages 321-329

  Raty R ^a   Franssila, K ^a   Jansson, S E ^a   Joensuu, H ^a   Wartiovaara Kautto, U ^a   Elonen, E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Blastoid variant; Histopathology; Mantle cell lymphoma; Non Hodgkin's lymphoma; Prognosis; Transformation

Indexed keywords

KI 67 ANTIGEN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MITOSIS; PREDICTION; PRIORITY JOURNAL; RISK; STAINING; SURVIVAL TIME; TIME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPHOCYTES; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037304863     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00456-2     Document Type: Article

References (29)

1. Banks P.M., Chan J., Cleary M.L.et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am. J. Surg. Pathol. 16:1992;637-640.
2. Harris N.L., Jaffe E.S., Stein H.et al. A revised European-American classification of lymphoid neoplasms. a proposal from the International Lymphoma Study Group Blood. 84:1994;1361-1392.
3. Zucca E., Stein H., Coiffier B. European Lymphoma Task Force (ELTF). report of the workshop on Mantle Cell Lymphoma (MCL) Ann. Oncol. 5:1994;507-511.
4. Segal G.H., Masih A.S., Fox A.C.et al. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood. 85:1995;1570-1579.
5. Norton A.J., Matthews J., Pappa V.et al. Mantle cell lymphoma. natural history defined in a serially biopsied population over a 20-year period Ann. Oncol. 6:1995;249-256.
6. Weisenburger D.D., Vose J.M., Greiner T.C.et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am. J. Hematol. 64:2000;190-196.
7. Yatabe Y., Suzuki R., Tobinai K.et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma. a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma Blood. 95:2000;2253-2261.
8. De Wolf-Peeters C., Pittaluga S. Mantle-cell lymphoma. Ann. Oncol. 5:1994;35-37.
9. Fisher R.I., Dahlberg S., Nathwani B.N.et al. A clinical analysis of two indolent lymphoma entities. mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study Blood. 85:1995;1075-1082.
10. Velders G.A., Kluin-Nelemans J.C., De Boer C.J.et al. Mantle-cell lymphoma. a population-based clinical study J. Clin. Oncol. 14:1996;1269-1274.
11. Zucca E., Roggero E., Pinotti G.et al. Patterns of survival in mantle cell lymphoma. Ann. Oncol. 6:1995;257-262.
12. Oinonen R., Franssila K., Teerenhovi L., Lappalainen K., Elonen E. Mantle cell lymphoma. clinical features, treatment and prognosis of 94 patients Eur. J. Cancer. 34:1998;329-336.
13. Bosch F., Lopez-Guillermo A., Campo E.et al. Mantle cell lymphoma. presenting features, response to therapy, and prognostic factors Cancer. 82:1998;567-575.
14. Teodorovic I., Pittaluga S., Kluin-Nelemans J.C.et al. Efficacy of four different regimens in 64 mantle-cell lymphoma cases. clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group J. Clin. Oncol. 13:1995;2819-2826.
15. Armitage J.O., Weisenburger D.D. New approach to classifying non-Hodgkin's lymphomas. clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project J. Clin. Oncol. 16:1998;2780-2795.
16. Argatoff L.H., Connors J.M., Klasa R.J., Horsman D.E., Gascoyne R.D. Mantle cell lymphoma. a clinicopathologic study of 80 cases Blood. 89:1997;2067-2078.
17. Bernard M., Gressin R., Lefére F.et al. Blastic variant of mantle cell lymphoma. a rare but highly aggressive subtype Leukemia. 15:2001;1785-1791.
18. Samaha H., Dumontet C., Ketterer N.et al. Mantle cell lymphoma. a retrospective study of 121 cases Leukemia. 12:1998;1281-1287.
19. International Agency for Research on Cancer (IARC). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. Lyon, IARC Press, 2001, 168-170.
20. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
21. Swerdlow S.H., Habeshaw J.A., Murray L.J.et al. Centrocytic lymphoma. a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse Am. J. Pathol. 113:1983;181-197.
22. Oinonen R., Franssila K., Elonen E. Central nervous system involvement in patients with mantle cell lymphoma. Ann. Hematol. 78:1999;145-149.
23. Montserrat E., Bosch F., Lopez-Guillermo A.et al. CNS involvement in mantle-cell lymphoma. J. Clin. Oncol. 14:1996;941-944.
24. Monni O., Oinonen R., Elonen E.et al. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer. 21:1998;298-307.
25. Bea S., Ribas M., Hernandez J.M.et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 93:1999;4365-4374.
26. Ott G., Kalla J., Ott M.M.et al. Blastoid variants of mantle cell lymphoma. frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones Blood. 89:1997;1421-1429.
27. Greiner T.C., Moynihan M.J., Chan W.C.et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood. 87:1996;4302-4310.
28. Pinyol M., Hernandez L., Cazorla M.et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood. 89:1997;272-280.
29. Grønbæk K., Nedergaard T., Andersen M.K.et al. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma. a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb Leukemia. 12:1998;1266-1271.